AI Proteins - About the company
AI Proteins is a series A company based in Boston (United States), founded in 2021. It operates as a Developer of de novo designed miniproteins for therapeutic applications. AI Proteins has raised $59.7M in funding from investors like Sante, Cobro Ventures and Mission BioCapital. The company has 70 active competitors, including 40 funded and 4 that have exited. Its top competitors include companies like Nimbus Therapeutics, Generate Biomedicines and Cradle.
Company Details
Developer of de novo designed miniproteins for therapeutic applications. The company engineers proteins from scratch, controlling function, selectivity, stability, and pharmacology. This allows for the creation of multivalent and multispecific constructs. The designed proteins are intended to minimize off-target effects, drug interactions, and unwanted immune responses. The company aims to deliver biologics that are potent, programmable, and safe.
- Website
- www.aiproteins.com/
- Email ID
- *****@aiproteins.com
Key Metrics
Founded Year
2021
Location
Boston, United States
Stage
Series A
Total Funding
$59.7M in 3 rounds
Latest Funding Round
Ranked
11th among 70 active competitors
Employee Count
39 as on Aug 31, 2026
Similar Companies
Sign up to download AI Proteins' company profile
AI Proteins's funding and investors
AI Proteins has raised a total funding of $59.7M over 3 rounds. Its first funding round was on Nov 03, 2022. Its latest funding round was a Series A round on Nov 20, 2025 for $*****. 4 investors participated in its latest round. AI Proteins has 5 institutional investors.
Here is the list of recent funding rounds of AI Proteins:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 20, 2025 | 6803203 | Series A | 4357829 | 4783763 | 8004886 | 6359776 |
2023 | 6586 | Grant (prize money) | 4082 | 3223 | 8065 | |
Nov 03, 2022 | 2829675 | Seed | 1079550 | 7215843 |
View details of AI Proteins's funding rounds and investors
AI Proteins' founders and board of directors
Founder? Claim ProfileAI Proteins' employee count trend
AI Proteins has 39 employees as of Aug 26. Here is AI Proteins's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
AI Proteins's Competitors and alternates
Top competitors of AI Proteins include Nimbus Therapeutics, Generate Biomedicines and Cradle. Here is the list of Top 10 competitors of AI Proteins, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Nimbus Therapeutics 2009, Cambridge (United States), Series F | Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases | $637M | 68/100 | |
2nd | Generate Biomedicines 2018, Somerville (United States), Public | Developer of a platform for generating novel protein-based therapeutic modalities | $693M | 66/100 | |
3rd | Cradle 2021, Zurich (Switzerland), Series B | Provider of chemoproteomics solutions for protein design and development | $103M | 64/100 | |
4th | EvolutionaryScale 2023, New York City (United States), Seed | Provider of an AI models for protein design | $142M | 64/100 | |
5th | Profluent Bio 2022, Berkeley (United States), Series B | Provider of an artificial intelligence-based protein design platform | $150M | 64/100 | |
6th | Frontier Medicines 2018, San Francisco (United States), Series C | Developer of a bioinformatics platform for drug development and chemoproteomics | $236M | 62/100 | |
7th | Eikon 2019, Millbrae (United States), Public | Protein tracking and measuring tool for drug discovery | $1.16B | 62/100 | |
8th | Seismic 2019, Watertown (United States), Series B | AI-assisted platform for drug discovery and development | $247M | 62/100 | |
9th | Orbit Discovery 2015, Oxford (United Kingdom), Series A | Developer of a drug discovery platforms by peptide display engine | $15.7M | 59/100 | |
10th | Converge 2024, Wilmington (United States), Series A | Developer of GenAI computational tools for drug discovery and manufacturing | $30.5M | 56/100 | |
11th | AI Proteins 2021, Boston (United States), Series A | Developer of de novo designed miniproteins for therapeutic applications | $59.7M | 56/100 |
Looking for more details on AI Proteins's competitors? Click here to see the top ones
AI Proteins's Investments and acquisitions
AI Proteins has made no investments or acquisitions yet.
Reports related to AI Proteins
Here is the latest report on AI Proteins's sector:
News related to AI Proteins
Media has covered AI Proteins for a total of 3 events in the last 1 year.
•
AI Proteins Raises $41.5M Series A Financing to Advance De Novo Miniproteins as a New Therapeutic Modalityintelligence360•Dec 19, 2025•AI Proteins, Sante, Mission BioCapital
•
•
•
AI Proteins Appoints James Bowman as First Chief Technology OfficerBusiness Wire•Aug 26, 2025•AI Proteins
•
AI Proteins to Present Key Advances in Miniprotein Therapeutics Development at PEGS Boston 2025
BioSpace•May 06, 2025•AI Proteins
•
AI Proteins Appoints Philip E. Brandish, PhD as Chief Development OfficerBusiness Wire•Feb 12, 2025•Bicycle, AI Proteins
•
BMS inks deal with AI Proteins; Terns’ early-stage leukemia dataEndPoints News•Dec 03, 2024•Bristol-Myers Squibb, AI Proteins
•
Bristol in research agreement with AI Proteins on miniprotein-based therapiesSeeking Alpha•Dec 03, 2024•Bristol-Myers Squibb, AI Proteins
•
•
AI Proteins Selected as a Winner of the Falling Walls Venture Science Start-up CompetitionBusiness Wire•Nov 06, 2024•AI Proteins
Are you a Founder ?
FAQs about AI Proteins
Explore our recently published companies
- Mentoring Education - Natal based, 2019 founded, Seed company
- Quality Roof - Chennai based, 2002 founded, Unfunded company
- KTK Janitorial - 2009 founded, Unfunded company
- britishanimalfeeds - United Kingdom based, 2019 founded, Unfunded company
- Nuproxa - Etoy based, 2007 founded, Unfunded company
- Think Local - 2015 founded, Unfunded company